Supplemental tables 1-6 from The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation
Year: 2023
Type: supplementary-materials
Abstract: Supplemental tables 1-6. Supplemental table 1: Patient Demographics and Baseline Characteristics. Supplemental table 2. Plasma Pharmacokinetic parameters. Supplemental table 3. Identification of metabolites of JNJ-38877605. Supplemental table 3. Identification of metabolites of JNJ-38877605. Supplementary table 5: noteworthy post-mortem changes – 1-month recovery phase. Supplementary table 6: noteworthy microscopic changes (Probenecid study.
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362395861